8CZG
Human BAK in complex with the dF3 peptide
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 24-ID-C |
| Synchrotron site | APS |
| Beamline | 24-ID-C |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2019-11-23 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.97920 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 48.290, 65.260, 111.570 |
| Unit cell angles | 90.00, 102.12, 90.00 |
Refinement procedure
| Resolution | 41.850 - 1.990 |
| R-factor | 0.2299 |
| Rwork | 0.228 |
| R-free | 0.26730 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | PDB:5VX0 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.20.1_4487) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 41.850 | 41.850 | 2.040 |
| High resolution limit [Å] | 1.990 | 8.890 | 1.990 |
| Rmerge | 0.149 | 0.044 | 0.715 |
| Rmeas | 0.170 | 0.049 | 0.825 |
| Total number of observations | 160024 | ||
| Number of reflections | 43206 | 471 | 2844 |
| <I/σ(I)> | 6 | 16.23 | 1.77 |
| Completeness [%] | 92.3 | 82.3 | 82.8 |
| Redundancy | 3.704 | 4.248 | 3.327 |
| CC(1/2) | 0.994 | 0.999 | 0.795 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 277 | PEG 3350 (20% w/v), 0.2 M calcium acetate |






